SK Plasma Invests 35.2 Billion KRW in Indonesian Subsidiary
SK Discovery, a KOSPI-listed company, announced on the 14th that its subsidiary SK Plasma will invest approximately 35.2 billion KRW in an Indonesian pharmaceutical manufacturing affiliate (PT. SKPLASMA CORE INDONESIA).
After the investment, the equity stake will be 29.6%.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- JD Vance: "Iran Must Agree to Abandon Nuclear Weapons... Military Action Remains an Option"
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
SK Discovery explained the purpose of this investment as "additional equity investment for the establishment and leading operation of a local blood product factory."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
